Assessment of [125I]a-Bungarotoxin Binding to a7 Nicotinic Acetylcholinergic Receptors in Hippocampus-Subiculum of Postmortem Human Parkinson’s Disease Brain
Biomolecules · 2025
DOI: 10.3390/biom15121686 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomolecules, 2025. Verfasst von Fariha Karim und 4 weiteren Autor:innen. Beteiligte Einrichtung: Preclinical Imaging, Department of Radiological Sciences, University of California-Irvine, Irvine, CA 92697, USA. Hauptthemen laut MEDLINE: Parkinson Disease, alpha7 Nicotinic Acetylcholine Receptor, Bungarotoxins, Hippocampus. Die Arbeit nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIA NIH HHS, NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
Parkinson’s disease (PD) involves motor and cognitive impairment that nicotinic acetylcholine receptors (nAChRs) such as the α7 subtype are responsible for regulating. The hippocampus, abundant in α7 nAChRs, was quantitatively evaluated for [125I]α-bungarotoxin ([125I]α-Bgtx) binding to α7 nAChRs in postmortem human PD (n = 26; 12 male, 14 female) and cognitively normal (CN) (n = 29; 14 male, 15 female) brain slices. Anti-ubiquitin and anti-α-synuclein immunostained adjacent slices were analyzed using QuPath. Autoradiographs of [125I]α-Bgtx radioligand binding were analyzed in OptiQuant. Ubiquitin and α-synuclein distribution generally aligned with the distribution of α7 nAChRs detected by [125I]α-Bgtx. Binding of [125I]α-Bgtx in PD cases was significantly greater than CN with a 32% increase in gray matter binding. A weak positive correlation between age and [125I]α-Bgtx binding was found in both PD and CN. In comparison to Alzheimer’s disease hippocampus, [125I]α-Bgtx binding in PD gray matter was higher by 41%. Differences in nAChR expression imply unique roles depending on the neurodegenerative pathology. PD may experience an increase in α7 nAChRs as a compensatory mechanism to the loss in neurons, highlighting its neuroprotective capabilities. [125I]α-Bgtx shows potential as a radioligand for α7 nAChRs to elucidate the complexities of PD pathology.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Preclinical Imaging, Department of Radiological Sciences, University of California-Irvine, Irvine, CA 92697, USA.
ORCID-Profile: Fariha Karim, Allyson Ngo, Titus E Tucker, Ashlee D L Coronel, Jogeshwar Mukherjee
Förderung
- NIA NIH HHS
- NIH HHS
- National Institutes of Health
Zitieren
APA
Karim, F., Ngo, A., Tucker, T. E., Coronel, A. D. L., & Mukherjee, J. (2025). Assessment of [125I]a-Bungarotoxin Binding to a7 Nicotinic Acetylcholinergic Receptors in Hippocampus-Subiculum of Postmortem Human Parkinson’s Disease Brain. Biomolecules. https://doi.org/10.3390/biom15121686
Vancouver
Karim F, Ngo A, Tucker TE, Coronel ADL, Mukherjee J. Assessment of [125I]a-Bungarotoxin Binding to a7 Nicotinic Acetylcholinergic Receptors in Hippocampus-Subiculum of Postmortem Human Parkinson’s Disease Brain. Biomolecules. 2025. doi:10.3390/biom15121686
BibTeX
@article{Karim2025,
author = {Karim, Fariha and Ngo, Allyson and Tucker, Titus E and Coronel, Ashlee D L and Mukherjee, Jogeshwar},
title = {Assessment of [125I]a-Bungarotoxin Binding to a7 Nicotinic Acetylcholinergic Receptors in Hippocampus-Subiculum of Postmortem Human Parkinson’s Disease Brain},
journal = {Biomolecules},
year = {2025},
doi = {10.3390/biom15121686}
}
EUVIMED